Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Psychological Medicine|July 30, 2025
AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trialsSergio Mena, Fiona Coutts, Jana von Trott, et al.
Schizophrenia Research|October 6, 2014
Effects of aripiprazole once-monthly on domains of personal and social performance: results from 2 multicenter, randomized, double-blind studiesW Wolfgang Fleischhacker, Ross A Baker, Anna Eramo, et al.
The Lancet. Psychiatry|February 21, 2021
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 studyW Wolfgang Fleischhacker, Jana Podhorna, Martina Gröschl, et al.
Clinical Schizophrenia & Related Psychoses|February 26, 2015
Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind StudiesJohn M Kane, Raymond Sanchez, Ross A Baker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2016
Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment settingAlexandra Kaufmann, Fabienne Wartelsteiner, Nursen Yalcin-Siedentopf, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 14, 2014
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority studyW Wolfgang Fleischhacker, Raymond Sanchez, Pamela P Perry, et al.
Schizophrenia Bulletin|June 14, 2015
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of SchizophreniaDavid Walling, Stephen R Marder, John Kane, et al.
The Journal of Clinical Psychiatry|March 29, 2008
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challengesW Wolfgang Fleischhacker, Marcelo Cetkovich-Bakmas, Marc De Hert, et al.
Schizophrenia Bulletin|May 25, 2016
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysisJian-Ping Zhang, Todd Lencz, Ryan X Zhang, et al.
Social Psychiatry and Psychiatric Epidemiology|February 2, 2010
Attitudes of patients with schizophrenia and depression to psychiatric research: a study in seven European countriesIngo Schäfer, Tom Burns, W Wolfgang Fleischhacker, et al.
Pageof 17